{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:53:14Z","timestamp":1793641994620,"version":"4.5.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03115-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:57:52Z","timestamp":1751399872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Synthesis and evaluation of thiazolyl coumarin drug conjugates as carbonic anhydrase isozyme inhibitors by using integrated invitro and insilico approaches"],"prefix":"10.1038","volume":"15","author":[{"given":"Atteeque","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaisa","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pervaiz Ali","family":"Channar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Y.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-7234","authenticated-orcid":false,"given":"Syeda Abida","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muhammad","family":"Attaullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifhat","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3115_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discovery. 7, 168\u2013181 (2008).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"3115_CR2","doi-asserted-by":"crossref","unstructured":"Supuran, C. T. Vol. 8 25 (MDPI, 2018).","DOI":"10.3390\/metabo8020025"},{"key":"3115_CR3","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1080\/14756366.2019.1664501","volume":"34","author":"S Akocak","year":"2019","unstructured":"Akocak, S. & Supuran, C. T. Activation of \u03b1-, \u03b2-, \u03b3-\u03b4-, \u03b6-and \u03b7-class of carbonic anhydrases with amines and amino acids: A review. J. Enzyme Inhib. Med. Chem. 34, 1652\u20131659 (2019).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"3115_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jinorgbio.2011.11.017","volume":"111","author":"G De Simone","year":"2012","unstructured":"De Simone, G. & Supuran, C. T. In) organic anions as carbonic anhydrase inhibitors. J. Inorg. Biochem. 111, 117\u2013129 (2012).","journal-title":"J. Inorg. Biochem."},{"key":"3115_CR5","doi-asserted-by":"crossref","unstructured":"Lomelino, C. L., Andring, J. T. & McKenna, R. Crystallography and its impact on carbonic anhydrase research. Int. J. Med. Chem. (2018). (2018).","DOI":"10.1155\/2018\/9419521"},{"key":"3115_CR6","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","volume":"15","author":"CT Supuran","year":"2007","unstructured":"Supuran, C. T. & Scozzafava, A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg. Med. Chem. 15, 4336\u20134350 (2007).","journal-title":"Bioorg. Med. Chem."},{"key":"3115_CR7","doi-asserted-by":"crossref","unstructured":"Haider, M. B. et al. Design, synthesis, characterization and exploration of biological efficacy of iminothiazoline sulfonamide hybrids as efficient inhibitor of carbonic anhydrase. J. Mol. Struct. 142331 (2025).","DOI":"10.1016\/j.molstruc.2025.142331"},{"key":"3115_CR8","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","volume":"37","author":"M Kciuk","year":"2022","unstructured":"Kciuk, M. et al. Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. J. Enzyme Inhib. Med. Chem. 37, 1278\u20131298 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"3115_CR9","doi-asserted-by":"crossref","unstructured":"Jaitak, A., Kumari, K., Kounder, S. & Monga, V. Carbonic anhydrases: moiety appended derivatives, medicinal and pharmacological implications. Bioorg.  Med. Chem., 117933 (2024).","DOI":"10.1016\/j.bmc.2024.117933"},{"key":"3115_CR10","doi-asserted-by":"publisher","first-page":"e2400748","DOI":"10.1002\/ardp.202400748","volume":"358","author":"KA Mishra","year":"2025","unstructured":"Mishra, K. A. & Sethi, K. K. Unveiling tomorrow: carbonic anhydrase activators and inhibitors pioneering new frontiers in Alzheimer\u2019s disease. Arch. Pharm. 358, e2400748 (2025).","journal-title":"Arch. Pharm."},{"key":"3115_CR11","doi-asserted-by":"publisher","first-page":"1511281","DOI":"10.3389\/fmolb.2025.1511281","volume":"12","author":"K D\u2019Ambrosio","year":"2025","unstructured":"D\u2019Ambrosio, K., Di Fiore, A. & Langella, E. Dual targeting carbonic anhydrase inhibitors as promising therapeutic approach: a structural overview. Front. Mol. Biosci. 12, 1511281 (2025).","journal-title":"Front. Mol. Biosci."},{"key":"3115_CR12","unstructured":"Nocentini, A., Capasso, C. & Supuran, C. (2023)."},{"key":"3115_CR13","doi-asserted-by":"publisher","first-page":"109326","DOI":"10.1016\/j.cbi.2020.109326","volume":"333","author":"M Petrenko","year":"2021","unstructured":"Petrenko, M. et al. Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX Inhibition results in additive effects on human breast cancer cells. Chemico-Biol. Interact. 333, 109326 (2021).","journal-title":"Chemico-Biol. Interact."},{"key":"3115_CR14","first-page":"2585","volume":"41","author":"A G\u00fcttler","year":"2019","unstructured":"G\u00fcttler, A. et al. Cellular and Radiobiological effects of carbonic anhydrase IX in human breast cancer cells. Oncol. Rep. 41, 2585\u20132594 (2019).","journal-title":"Oncol. Rep."},{"key":"3115_CR15","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.3390\/ijms20236080","volume":"20","author":"KJ Williams","year":"2019","unstructured":"Williams, K. J. & Gieling, R. G. Preclinical evaluation of ureidosulfamate carbonic anhydrase IX\/XII inhibitors in the treatment of cancers. Int. J. Mol. Sci. 20, 6080 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"3115_CR16","doi-asserted-by":"crossref","unstructured":"Vogel, A. J. A. D. P. Darstellung von benzoes\u00e4ure Aus D.r Tonka-Bohne und Aus D.n Meliloten\u2010oder Steinklee\u2010Blumen. 64, 161\u2013166 (1820).","DOI":"10.1002\/andp.18200640205"},{"key":"3115_CR17","unstructured":"Guibourt, N. J. B. G. Histoire Abr\u00e9g\u00e9e Des Drogues Simples, Vol. 1 (M\u00e9quignon-Marvis, 1826)."},{"key":"3115_CR18","doi-asserted-by":"crossref","unstructured":"Peng, X. M., Damu, L. V. & Zhou, H. G.J. C.  Current developments of coumarin compounds in medicinal chemistry. 19, 3884\u20133930 (2013).","DOI":"10.2174\/1381612811319210013"},{"key":"3115_CR19","doi-asserted-by":"crossref","unstructured":"Lafitte, D. et al. DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5 \u2018-methyl group of the noviose. 41, 7217\u20137223 (2002).","DOI":"10.1021\/bi0159837"},{"key":"3115_CR20","doi-asserted-by":"crossref","unstructured":"Curir, P., Galeotti, F., Dolci, M., Barile, E. & Lanzotti, V. J.  Pavietin, a coumarin from Aesculus P.via with antifungal activity. 70, 1668\u20131671 (2007).","DOI":"10.1021\/np070295v"},{"key":"3115_CR21","doi-asserted-by":"crossref","unstructured":"Satyanarayana, V., Sreevani, P., Sivakumar, A. & Vijayakumar, V. J. A. Synthesis and antimicrobial activity of new schiff bases containing coumarin moiety and their spectral characterization. 17, 221\u2013233 (2008).","DOI":"10.3998\/ark.5550190.0009.h21"},{"key":"3115_CR22","doi-asserted-by":"crossref","unstructured":"Arshad, A. et al. Synthesis and antimicrobial properties of some new Thiazolyl coumarin derivatives. 46, 3788\u20133794 (2011).","DOI":"10.1016\/j.ejmech.2011.05.044"},{"key":"3115_CR23","doi-asserted-by":"crossref","unstructured":"Anderson, D. M., Shelley, S., Crick, N. & Buraglio, M. J. T. No effect O. the novel antidiabetic agent nateglinide O. the pharmacokinetics and anticoagulant properties O. warfarin in healthy volunteers. 42, 1358\u20131365 (2002).","DOI":"10.1177\/0091270002238772"},{"key":"3115_CR24","unstructured":"T\u00e0ssies, D. et al. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation. 87, 1185\u20131191 (2002)."},{"key":"3115_CR25","doi-asserted-by":"crossref","unstructured":"Weick, J. & Thorn, R. S. Effects O. acute sublethal E.posure to coumaphos O. Diazinon O. acquisition and discrimination O. O.or stimuli in the honey bee (Hymenoptera: Apidae). 95, 227\u2013236 (2002).","DOI":"10.1603\/0022-0493-95.2.227"},{"key":"3115_CR26","first-page":"954","volume":"7","author":"JS Shia","year":"2024","unstructured":"Shia, J. S. et al. Exploring the multifaceted biological activities of 4-((5-Amino-1, 3, 4-Thiadiazol-2-yl) Methoxy) coumarin: antioxidant, antibacterial, and antifungal properties. J. Med. Chem. Sci. 7, 954\u2013968 (2024).","journal-title":"J. Med. Chem. Sci."},{"key":"3115_CR27","doi-asserted-by":"crossref","unstructured":"Stone, W. B., Okoniewski, J. C. & Stedelin, J. R. Poisoning of wildlife with anticoagulant rodenticides in New York. 35, 187\u2013193 (1999).","DOI":"10.7589\/0090-3558-35.2.187"},{"key":"3115_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/14756360409162453","volume":"19","author":"KM Khan","year":"2004","unstructured":"Khan, K. M. et al. Synthesis of coumarin derivatives with cytotoxic, antibacterial and antifungal activity. J. Enzyme Inhib. Med. Chem. 19, 373\u2013379 (2004).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"3115_CR29","first-page":"2123","volume":"21","author":"SJ Kashyap","year":"2012","unstructured":"Kashyap, S. J. et al. Thiazoles: Having Diverse Biol. Activities 21, 2123\u20132132 (2012).","journal-title":"Thiazoles: Having Diverse Biol. Activities"},{"key":"3115_CR30","doi-asserted-by":"crossref","unstructured":"Desai, N., Bhatt, N., Somani, H. & Trivedi, A. J. Synthesis, antimicrobial and C.totoxic activities O. some novel thiazole C.ubbed 1, 3, 4-oxadiazoles. 67, 54\u201359 (2013).","DOI":"10.1016\/j.ejmech.2013.06.029"},{"key":"3115_CR31","first-page":"270","volume":"62","author":"S Bondock","year":"2013","unstructured":"Bondock, S., Naser, T. & Ammar, Y. A. Synthesis of some new 2-(3-pyridyl)-4, 5-disubstituted thiazoles as potent antimicrobial agents. J. E J. O M C. 62, 270\u2013279 (2013).","journal-title":"J. E J. O M C"},{"key":"3115_CR32","doi-asserted-by":"crossref","unstructured":"Vukovic, N., Sukdolak, S., Solujic, S. & Milosevic, T. J. A. Synthesis and antimicrobial evaluation of some novel 2-Aminothiazole derivatives of 4\u2010Hydroxy\u2010chromene\u20102\u2010one. 341, 491\u2013496 (2008).","DOI":"10.1002\/ardp.200700215"},{"key":"3115_CR33","doi-asserted-by":"crossref","unstructured":"Chimenti, F. et al. Synthesis and anti-Helicobacter pylori Activity of 4\u2010(Coumarin\u20103\u2010yl) thiazol\u20102\u2010ylhydrazone Derivatives. 42 (2011).","DOI":"10.1002\/chin.201113132"},{"key":"3115_CR34","first-page":"236","volume":"123","author":"MZ Hassan","year":"2016","unstructured":"Hassan, M. Z., Osman, H., Ali, M. A. & Ahsan, M. J. Therapeutic potential of coumarins as antiviral agents. J. E J. O M C. 123, 236\u2013255 (2016).","journal-title":"J. E J. O M C"},{"key":"3115_CR35","doi-asserted-by":"crossref","unstructured":"Olomola, T. O., Klein, R., Lobb, K. A., Sayed, Y. & Kaye, P. T. Towards the synthesis of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors. 51, 6325\u20136328 (2010).","DOI":"10.1016\/j.tetlet.2010.09.121"},{"key":"3115_CR36","doi-asserted-by":"crossref","unstructured":"Osman, H. et al. New thiazolyl-coumarin hybrids: design, synthesis, characterization, X-ray crystal structure, antibacterial and antiviral evaluation. 1166, 147\u2013154 (2018).","DOI":"10.1016\/j.molstruc.2018.04.031"},{"key":"3115_CR37","doi-asserted-by":"crossref","unstructured":"Ramagiri, R. K. et al. A facile one-step multi-component approach T.ward T.e synthesis of 3-(2-amino-4-thiazolyl) coumarins by using T.imethylsilyl isothiocyanate and T.eir antioxidant and anti-inflammatory activity. 190, 1393\u20131397 (2015).","DOI":"10.1080\/10426507.2014.990016"},{"key":"3115_CR38","doi-asserted-by":"crossref","unstructured":"Sharma, A. Advances in Structure and Activity Relationship of Coumarin Derivatives, 119\u2013136 (Elsevier, 2016).","DOI":"10.1016\/B978-0-12-803797-3.00006-0"},{"key":"3115_CR39","unstructured":"Rahman, F. S. A., Yusufzai, S. K., Osman, H. & Mohamad, D. Synthesis, characterisation and cytotoxicity activity of thiazole substitution of coumarin derivatives (characterisation of coumarin derivatives). 27, 77 (2016)."},{"key":"3115_CR40","doi-asserted-by":"crossref","unstructured":"Emami, S. & Dadashpour, S. J.  Current developments O. coumarin-based anti-cancer agents in medicinal chemistry. 102, 611\u2013630 (2015).","DOI":"10.1016\/j.ejmech.2015.08.033"},{"key":"3115_CR41","doi-asserted-by":"crossref","unstructured":"Satish, G. Advances in Structure and Activity Relationship of Coumarin Derivatives, 151\u2013159 (Elsevier, 2016).","DOI":"10.1016\/B978-0-12-803797-3.00008-4"},{"key":"3115_CR42","doi-asserted-by":"crossref","unstructured":"Matos, M. et al. Heterocyclic antioxidants in nature: coumarins 21, 311\u2013324 (2017).","DOI":"10.2174\/1385272820666161017170652"},{"key":"3115_CR43","doi-asserted-by":"crossref","unstructured":"Kostova, I. et al. Coumarins as antioxidants 18, 3929\u20133951 (2011).","DOI":"10.2174\/092986711803414395"},{"key":"3115_CR44","doi-asserted-by":"crossref","unstructured":"Al-Majedy, Y., Al-Amiery, A., Kadhum, A. A., & BakarMohamad, A. Antioxidant activity of coumarins. Syst. Rev.Pharm. 8 (1), 24 (2017).","DOI":"10.5530\/srp.2017.1.6"},{"key":"3115_CR45","unstructured":"Siddiqui, N., Arshad, M. F. & Khan, S. A. Synthesis of some new coumarin incorporated Thiazolyl semicarbazones as anticonvulsants. Acta Pol. Pharm. 66, 161\u2013167 (2009)."},{"key":"3115_CR46","doi-asserted-by":"crossref","unstructured":"Raval, J. P., Desai, J. T., Desai, C. K. & Desai, K. R. J. A. A comparative study of microwave assisted and conventional synthesis of 2, 3-dihydro-2-aryl-4-[4-(2\u2013oxo\u20132H\u2013chromen\u20133\u2013yl)\u20131, 3-thiazol\u20132\u2013ylamino]-1, 5\u2013benzothiazepines and its antimicrobial activity. 12, 233\u2013244 (2008).","DOI":"10.3998\/ark.5550190.0009.c25"},{"key":"3115_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF03245817","volume":"5","author":"J Desai","year":"2008","unstructured":"Desai, J., Desai, C. & Desai, K. J. A convenient, rapid and eco-friendly synthesis of isoxazoline heterocyclic moiety containing Bridge at 2-amine as potential Pharmacological agent. J. Iran. Chem. Soc.. 5, 67\u201373 (2008).","journal-title":"J. Iran. Chem. Soc."},{"key":"3115_CR48","doi-asserted-by":"crossref","unstructured":"Ansari, M. I., Khan, S. A. Synthesis and antimicrobial activity of some novel quinoline-pyrazoline-based coumarinyl thiazole derivatives. 26, 1481\u20131496 (2017).","DOI":"10.1007\/s00044-017-1855-4"},{"key":"3115_CR49","doi-asserted-by":"crossref","unstructured":"Parveen, S. et al. Computational and biological studies of novel Thiazolyl coumarin derivatives synthesized through Suzuki coupling. 44, 1610\u20131622 (2020).","DOI":"10.3906\/kim-2005-19"},{"key":"3115_CR50","doi-asserted-by":"crossref","unstructured":"Kathiravan, M. K. et al. The biology and chemistry of antifungal agents: A review. 20, 5678\u20135698 (2012).","DOI":"10.1016\/j.bmc.2012.04.045"},{"key":"3115_CR51","doi-asserted-by":"crossref","unstructured":"Sonmez, F. et al. Design, synthesis and Docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors. 32, 285\u2013297 (2017).","DOI":"10.1080\/14756366.2016.1250753"},{"key":"3115_CR52","doi-asserted-by":"crossref","unstructured":"Madni, M. et al. Synthesis, quantum chemical, in vitro acetyl cholinesterase Inhibition and molecular Docking studies of four new coumarin based Pyrazolylthiazole nuclei. 1168, 175\u2013186 (2018).","DOI":"10.1016\/j.molstruc.2018.05.017"},{"key":"3115_CR53","doi-asserted-by":"crossref","unstructured":"Saeed, A. et al. 3-(5-(Benzylideneamino) thiazol-3-yl)-2 H-chromen-2-ones: A new class of alkaline phosphatase and ecto-5\u2032-nucleotidase inhibitors. 6, 21026\u201321036 (2016).","DOI":"10.1039\/C5RA24684A"},{"key":"3115_CR54","unstructured":"Meeran, I. S., Tajudeen, S. S., Dusthakeer, V. A. & Shabeer, T. An Insight into the Anti-Tubercular Potential of Schiff Bases."},{"key":"3115_CR55","doi-asserted-by":"crossref","unstructured":"Kurt, B. Z. et al. Synthesis, antioxidant and carbonic anhydrase I and II inhibitory activities of novel sulphonamide-substituted Coumarylthiazole derivatives. 31, 991\u2013998 (2016).","DOI":"10.3109\/14756366.2015.1077823"},{"key":"3115_CR56","doi-asserted-by":"publisher","first-page":"130821","DOI":"10.1016\/j.molstruc.2021.130821","volume":"1243","author":"A Saeed","year":"2021","unstructured":"Saeed, A., Ejaz, S. A., Ul-Hamid, A., El-Seedi, H. R. & Iqbal, J. Synthesis of and molecular Docking studies of azomethine-tethered sulfonamides as carbonic anhydrase II & 15-lipoxygenase inhibitors. J. Mol. Struct. 1243, 130821 (2021).","journal-title":"J. Mol. Struct."},{"key":"3115_CR57","doi-asserted-by":"publisher","first-page":"8946","DOI":"10.1080\/10406638.2022.2157027","volume":"43","author":"A Saeed","year":"2023","unstructured":"Saeed, A. et al. Biochemical characterization, and in-Silico investigations of Acyl-3-(Ciprofloxacinyl) thioureas as inhibitors of carbonic Anhydrase-II. Polycycl. Aromat. Compd. 43, 8946\u20138964 (2023). Synthesis.","journal-title":"Polycycl. Aromat. Compd."},{"key":"3115_CR58","doi-asserted-by":"publisher","first-page":"18461","DOI":"10.1039\/D3RA03276K","volume":"13","author":"T Hussain","year":"2023","unstructured":"Hussain, T. et al. Synthesis, characterization and biological evaluation of pyrazole-based benzene sulfonamides as inhibitors of human carbonic anhydrase II, IX and XII. RSC Adv. 13, 18461\u201318479 (2023).","journal-title":"RSC Adv."},{"key":"3115_CR59","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.bmc.2015.03.054","volume":"23","author":"M Al-Rashida","year":"2015","unstructured":"Al-Rashida, M. et al. Diarylsulfonamides and their bioisosteres as dual inhibitors of alkaline phosphatase and carbonic anhydrase: structure activity relationship and molecular modelling studies. Bioorg. Med. Chem. 23, 2435\u20132444 (2015).","journal-title":"Bioorg. Med. Chem."},{"key":"3115_CR60","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/14756366.2021.2024528","volume":"37","author":"WM Eldehna","year":"2022","unstructured":"Eldehna, W. M. et al. Discovery of 2, 4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms. J. Enzyme Inhib. Med. Chem. 37, 531\u2013541 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"3115_CR61","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.ijbiomac.2020.09.043","volume":"163","author":"B Sever","year":"2020","unstructured":"Sever, B., T\u00fcrke\u015f, C., Alt\u0131ntop, M. D., Demir, Y. & Beydemir, \u015e. Thiazolyl-pyrazoline derivatives: in vitro and in Silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors. Int. J. Biol. Macromol. 163, 1970\u20131988 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"3115_CR62","doi-asserted-by":"crossref","unstructured":"Ibrar, A., Shehzadi, S. A., Saeed, F. & Khan, I. Developing hybrid M.lecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery. 26, 3731\u20133762 (2018).","DOI":"10.1016\/j.bmc.2018.05.042"},{"key":"3115_CR63","doi-asserted-by":"crossref","unstructured":"Zhang, L. & Xu, Z. J. E. Coumarin-containing hybrids and their anticancer activities. 181, 111587 (2019).","DOI":"10.1016\/j.ejmech.2019.111587"},{"key":"3115_CR64","doi-asserted-by":"publisher","first-page":"89919","DOI":"10.1039\/C5RA14900B","volume":"5","author":"A Ibrar","year":"2015","unstructured":"Ibrar, A. et al. Facile and expedient access to bis-coumarin\u2013iminothiazole hybrids by molecular hybridization approach: synthesis, molecular modelling and assessment of alkaline phosphatase Inhibition, anticancer and antileishmanial potential. RSC Adv. 5, 89919\u201389931 (2015).","journal-title":"RSC Adv."},{"key":"3115_CR65","doi-asserted-by":"crossref","unstructured":"Woodring, J. L. et al. Disrupting the conserved salt Bridge in the trimerization of influenza A nucleoprotein. 63, 205\u2013215 (2019).","DOI":"10.1021\/acs.jmedchem.9b01244"},{"key":"3115_CR66","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1039\/D1RA07844E","volume":"12","author":"D Ali","year":"2022","unstructured":"Ali, D. et al. Utilization of transition metal fluoride-based solid support catalysts for the synthesis of sulfonamides: carbonic anhydrase inhibitory activity and in Silico study. RSC Adv. 12, 3165\u20133179 (2022).","journal-title":"RSC Adv."},{"key":"3115_CR67","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1021\/ci960402j","volume":"37","author":"ML Swift","year":"1997","unstructured":"Swift, M. L. GraphPad Prism, data analysis, and scientific graphing. J. Chem. Inf. Comput. Sci. 37, 411\u2013412 (1997).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"3115_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00894-021-04795-0","volume":"27","author":"J Hossen","year":"2021","unstructured":"Hossen, J., Ali, M. A. & Reza, S. Theoretical investigations on the antioxidant potential of a non-phenolic compound thymoquinone: a DFT approach. J. Mol. Model. 27, 173 (2021).","journal-title":"J. Mol. Model."},{"key":"3115_CR69","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.saa.2014.10.012","volume":"136","author":"K Bhavani","year":"2015","unstructured":"Bhavani, K., Renuga, S. & Muthu, S. Quantum mechanical study and spectroscopic (FT-IR, FT-Raman, 13\u00a0C, 1H) study, first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of 2-acetoxybenzoic acid by density functional methods. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 136, 1260\u20131268 (2015).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"3115_CR70","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1063\/1.460367","volume":"94","author":"MP McGrath","year":"1991","unstructured":"McGrath, M. P. & Radom, L. Extension of Gaussian-1 (G1) theory to bromine\u2010containing molecules. J. Chem. Phys. 94, 511\u2013516 (1991).","journal-title":"J. Chem. Phys."},{"key":"3115_CR71","doi-asserted-by":"publisher","first-page":"131212","DOI":"10.1016\/j.molstruc.2021.131212","volume":"1246","author":"U Vanitha","year":"2021","unstructured":"Vanitha, U., Elancheran, R., Manikandan, V., Kabilan, S. & Krishnasamy, K. Design, synthesis, characterization, molecular Docking and computational studies of 3-phenyl-2-thioxoimidazolidin-4-one derivatives. J. Mol. Struct. 1246, 131212 (2021).","journal-title":"J. Mol. Struct."},{"key":"3115_CR72","unstructured":"Dennington, R., Keith, T. A. & Millam, J. M. GaussView 6.0.16. (Semichem Inc., 2016)."},{"key":"3115_CR73","doi-asserted-by":"crossref","unstructured":"Burley, S. K. et al. Protein data bank (PDB): The single global macromolecular structure archive. Protein Crystallogr. Methods Protocols, 627\u2013641 (2017).","DOI":"10.1007\/978-1-4939-7000-1_26"},{"key":"3115_CR74","doi-asserted-by":"crossref","unstructured":"Prieto-Mart\u00ednez, F. D., Arciniega, M. & Medina-Franco, J. L. Molecular docking: current advances and challenges. TIP. Rev. Especi. Cienc. Qu\u00edmico-Biol. 21 (2018).","DOI":"10.22201\/fesz.23958723e.2018.0.143"},{"key":"3115_CR75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/pro.3934","volume":"30","author":"DS Goodsell","year":"2021","unstructured":"Goodsell, D. S., Sanner, M. F., Olson, A. J. & Forli, S. The AutoDock suite at 30. Protein Sci. 30, 31\u201343 (2021).","journal-title":"Protein Sci."},{"key":"3115_CR76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2505\/4\/tst14_081_06_67","volume":"81","author":"T Brown","year":"2014","unstructured":"Brown, T. & ChemDraw Sci. Teacher 81, 67 (2014).","journal-title":"Sci. Teacher"},{"key":"3115_CR77","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1038\/s41598-022-10253-5","volume":"12","author":"M Aziz","year":"2022","unstructured":"Aziz, M. et al. Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach. Sci. Rep. 12, 6404 (2022).","journal-title":"Sci. Rep."},{"key":"3115_CR78","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.3390\/ijms20184612","volume":"20","author":"A Daina","year":"2019","unstructured":"Daina, A. & Zoete, V. Application of the SwissDrugDesign online resources in virtual screening. Int. J. Mol. Sci. 20, 4612 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"3115_CR79","doi-asserted-by":"crossref","unstructured":"Jia, C. Y., Li, J. Y., Hao, G. F. & Yang, G.-F. A drug-likeness toolbox facilitates ADMET study in drug discovery. Drug Discov.Today. 25, 248\u2013258 (2020).","DOI":"10.1016\/j.drudis.2019.10.014"},{"key":"3115_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3\u201325 (1997).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"3115_CR81","doi-asserted-by":"publisher","first-page":"131548","DOI":"10.1016\/j.ijbiomac.2024.131548","volume":"268","author":"P Singh","year":"2024","unstructured":"Singh, P. et al. Design, synthesis and in vitro evaluation of novel thiazole-coumarin hybrids as selective and potent human carbonic anhydrase IX and XII inhibitors. Int. J. Biol. Macromol. 268, 131548 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"3115_CR82","doi-asserted-by":"publisher","first-page":"2200232","DOI":"10.1002\/ardp.202200232","volume":"355","author":"PS Thacker","year":"2022","unstructured":"Thacker, P. S. et al. Synthesis and biological evaluation of coumarin-thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors. Arch. Pharm. 355, 2200232 (2022).","journal-title":"Arch. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03115-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:58:01Z","timestamp":1751399881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03115-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3115"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03115-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22032"}}